Skip to main content

Ectoine. Nature’s strategy for balance, powered by water.

Ectoine is an extremolyte naturally produced by microorganisms to support water balance under extreme environmental stress. Its science centres on a distinctive relationship with water.

Discover how it works with water

Ectoin® is a trademark of bitop AG; ectoine is the scientific name of the molecule.

A strategy shaped by extreme environments.

The story begins with microorganisms adapted to the intense salinity of Wadi El Natrun in Egypt. Ectoine was first described in scientific literature in 1985 as part of this strategy for life.

These microorganisms accumulate ectoine as environmental stress rises. As a compatible solute, it can support water balance without markedly disrupting normal cellular processes.

bitop AG reports producing Ectoin® through biotechnology rather than harvesting it from nature—bringing a natural adaptation strategy into a controlled, scalable process.

Ectoine’s story begins with water.

At the molecular level, ectoine interacts strongly with water and tends to remain away from biomolecular surfaces. Science describes this water-rich microenvironment model as “preferential hydration.”

Biomolecular surface
  • Dense water layer
  • Ectoine
Conceptual illustration; molecule sizes, concentrations, and distances are not to scale.
  1. 01

    It becomes strongly hydrated.

    Ectoine’s distribution of electrical charge enables dense interaction with nearby water molecules. Research points to an effect centred on the local organisation of water.

  2. 02

    It stays away from biological surfaces.

    Ectoine has been observed to remain preferentially excluded rather than accumulate at protein and model-membrane surfaces. This behaviour supports water remaining close to the surface.

  3. 03

    It supports a water-rich environment.

    In molecular and model-membrane studies, this hydration environment has been associated with structural stability under stress.

A way to tell the water story: Ectoin Hydro-Complex

bitop uses “Ectoin Hydro-Complex” to visualise this water-mediated model. It is not a separate chemical compound, but a corporate expression for preferential hydration. Practical outcomes are assessed by concentration, formulation, and intended use.

Science that moves from molecule to formulation.

Ectoine research spans three complementary levels. Read together, they connect molecular mechanism with real formulation contexts.

  1. LEVEL 1

    Molecular mechanism

    Preferential hydration is consistently supported across water, protein, and model-membrane studies using converging methods.

    Strong mechanistic foundation

  2. LEVEL 2

    Biological models

    Cell and tissue models explore how ectoine interacts with biological systems under stress.

    Supports biological plausibility

  3. LEVEL 3

    Finished formulations

    Human studies exist for ectoine-containing skin, ocular, and upper-airway formulations. Findings are assessed by product, dose, and intended use.

    Product- and use-specific evidence

Three barrier surfaces in scientific focus.

Finished ectoine-containing formulations have been studied across surfaces that directly meet the external environment. Evidence is read in the context of the product, not the molecule alone.

Skin barrier

Research focusTopical formulations have been studied for outcomes including dryness, symptom scores, and transepidermal water loss, with positive signals reported in some studies.

How to read itThe evidence base is small; formulations differ and most include other moisturising ingredients. Findings are product-specific.

Ocular surface

Research focusEctoine-containing drops and sprays have been studied in contexts including dry eye, allergy-related irritation, and comfort after procedures.

How to read itA substantial share of studies are small or not placebo-controlled. Findings do not support a universal treatment claim.

Nasal and upper airway

Research focusNasal and upper-airway formulations have been assessed with symptom and examination measures, with positive signals in selected outcomes.

How to read itStudies are short and heterogeneous; different products and comparators do not carry the same level of evidence.

Ectoine’s water-mediated mechanism is well grounded. Human evidence offers promising signals in specific formulations; every finding is assessed in the context of its product and intended use.

Trust also means being clear about the limits of science.

  • 01An ingredient-level mechanism does not mean every ectoine-containing product will produce the same effect.
  • 02Laboratory and preclinical findings are not, by themselves, claims of disease treatment or prevention.
  • 03Each finished formulation is assessed by its own evidence, intended use, and regulatory status.

ectoCare® is preparing for Türkiye.

Contact Eragenia for developments in Türkiye and corporate partnership opportunities.

Contact us

Follow the science.

Featured publications trace ectoine’s scientific journey from its natural origin and water-mediated mechanism to formulation research.

  1. 01

    Galinski EA, Pfeiffer HP, Trüper HG (1985)

    1,4,5,6-Tetrahydro-2-methyl-4-pyrimidinecarboxylic acid. A novel cyclic amino acid from halophilic phototrophic bacteria of the genus Ectothiorhodospira. European Journal of Biochemistry. DOI: 10.1111/j.1432-1033.1985.tb08903.x

    DOI
  2. 02

    Zaccai G, Bagyan I, Combet J, et al. (2016)

    Neutrons describe ectoine effects on water H-bonding and hydration around a soluble protein and a cell membrane. Scientific Reports. DOI: 10.1038/srep31434

    DOI
  3. 03

    Casale M, Moffa A, Carbone S, et al. (2019)

    Topical Ectoine: A Promising Molecule in the Upper Airways Inflammation—A Systematic Review. BioMed Research International. DOI: 10.1155/2019/7150942

    DOI
  4. 04

    Kauth M, Trusova OV (2022)

    Topical Ectoine Application in Children and Adults to Treat Inflammatory Diseases Associated with an Impaired Skin Barrier: A Systematic Review. Dermatology and Therapy. DOI: 10.1007/s13555-021-00676-9

    DOI
  5. 05

    Bilstein A, Heinrich A, Rybachuk A, Mösges R (2021)

    Ectoine in the Treatment of Irritations and Inflammations of the Eye Surface. BioMed Research International. DOI: 10.1155/2021/8885032

    DOI
Show 4 supporting references
  1. 06

    Yu I, Jindo Y, Nagaoka M (2007)

    Microscopic understanding of preferential exclusion of compatible solute ectoine: direct interaction and hydration alteration. The Journal of Physical Chemistry B. DOI: 10.1021/jp068367z

    DOI
  2. 07

    Harishchandra RK, Wulff S, Lentzen G, Neuhaus T, Galla H-J (2010)

    The effect of compatible solute ectoines on the structural organization of lipid monolayer and bilayer membranes. Biophysical Chemistry. DOI: 10.1016/j.bpc.2010.02.007

    DOI
  3. 08

    Sahle CJ, Schroer MA, Jeffries CM, Niskanen J (2018)

    Hydration in aqueous solutions of ectoine and hydroxyectoine. Physical Chemistry Chemical Physics. DOI: 10.1039/C8CP05308A

    DOI
  4. 09

    Unfried K, Krämer U, Sydlik U, et al. (2016)

    Reduction of neutrophilic lung inflammation by inhalation of the compatible solute ectoine: a randomized trial with elderly individuals. International Journal of Chronic Obstructive Pulmonary Disease. DOI: 10.2147/COPD.S115061

    DOI

CORPORATE SOURCE

The bitop AG ectoine page was reviewed as the corporate source for history, biotechnological fermentation, the Hydro-Complex narrative, and fields of research.

bitop AG — Ectoin

Transparency note: some ectoine publications involve bitop AG employment, authorship, or sponsorship. Study design, comparators, and source relationships were considered together when preparing this content.

Scientific content search: 20 July 2026